$BHVN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Biohaven Pharmaceutical Holding Co Ltd..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Biohaven Pharmaceutical Holding Co Ltd.. Get notifications about new insider transactions in Biohaven Pharmaceutical Holding Co Ltd. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 07 2021 | BHVN | Biohaven Pharmaceu ... | CHILDS JOHN W | Option Exercise | A | 71.94 | 11,996 | 862,992 | 11,996 | ||
May 07 2021 | BHVN | Biohaven Pharmaceu ... | Doogan Declan | Option Exercise | A | 71.94 | 11,996 | 862,992 | 11,996 | ||
May 07 2021 | BHVN | Biohaven Pharmaceu ... | HUGIN ROBERT J | Option Exercise | A | 71.94 | 11,996 | 862,992 | 11,996 | ||
May 07 2021 | BHVN | Biohaven Pharmaceu ... | Heffernan Michael Thomas | Option Exercise | A | 71.94 | 11,996 | 862,992 | 11,996 | ||
Mar 17 2021 | BHVN | Biohaven Pharmaceu ... | CHILDS JOHN W | Buy | P | 76.00 | 13,157 | 999,932 | 2,545,801 | 2.5 M to 2.5 M (+0.52 %) | |
Mar 03 2021 | BHVN | Biohaven Pharmaceu ... | CHILDS JOHN W | Buy | P | 85.14 | 10,000 | 851,370 | 2,532,644 | 2.5 M to 2.5 M (+0.40 %) | |
Feb 12 2021 | BHVN | Biohaven Pharmaceu ... | CHILDS JOHN W | Buy | J | 0.00 | 5,706 | 0 | 2,522,644 | 2.5 M to 2.5 M (+0.23 %) | |
Feb 12 2021 | BHVN | Biohaven Pharmaceu ... | CHILDS JOHN W | Buy | J | 0.00 | 5,706 | 0 | 2,522,644 | 2.5 M to 2.5 M (+0.23 %) | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Option Exercise | M | 0.00 | 1,250 | 0 | 3,750 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Option Exercise | A | 83.38 | 10,000 | 833,800 | 10,000 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Payment of Exercise | F | 83.38 | 492 | 41,023 | 2,659 | 3.2 K to 2.7 K (-15.61 %) |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Buy | M | 0.00 | 1,250 | 0 | 3,151 | 1.9 K to 3.2 K (+65.75 %) |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Option Exercise | M | 0.00 | 5,000 | 0 | 15,000 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Option Exercise | A | 83.38 | 40,000 | 3,335,200 | 40,000 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Payment of Exercise | F | 83.38 | 2,124 | 177,099 | 7,127 | 9.3 K to 7.1 K (-22.96 %) |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Buy | M | 0.00 | 5,000 | 0 | 9,251 | 4.3 K to 9.3 K (+117.62 %) |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Option Exercise | M | 0.00 | 1,250 | 0 | 3,750 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Option Exercise | M | 0.00 | 3,750 | 0 | 11,250 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Option Exercise | A | 83.38 | 30,000 | 2,501,400 | 30,000 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Buy | M | 0.00 | 1,250 | 0 | 2,187 | 937 to 2.2 K (+133.40 %) |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Payment of Exercise | F | 83.38 | 1,747 | 145,665 | 5,691 | 7.4 K to 5.7 K (-23.49 %) |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Buy | M | 0.00 | 3,750 | 0 | 7,438 | 3.7 K to 7.4 K (+101.68 %) |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | SVP, Clinical Opera ... | Option Exercise | M | 0.00 | 3,750 | 0 | 11,250 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | SVP, Clinical Opera ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | SVP, Clinical Opera ... | Option Exercise | A | 83.38 | 30,000 | 2,501,400 | 30,000 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | SVP, Clinical Opera ... | Payment of Exercise | F | 83.38 | 1,747 | 145,665 | 7,691 | 9.4 K to 7.7 K (-18.51 %) |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | SVP, Clinical Opera ... | Buy | M | 0.00 | 3,750 | 0 | 9,438 | 5.7 K to 9.4 K (+65.93 %) |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,750 | 0 | 11,250 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Option Exercise | A | 83.38 | 30,000 | 2,501,400 | 30,000 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Payment of Exercise | F | 83.38 | 1,747 | 145,665 | 9,211 | 11 K to 9.2 K (-15.94 %) |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Buy | M | 0.00 | 3,750 | 0 | 10,958 | 7.2 K to 11 K (+52.03 %) |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Conway Charles | Chief Scientific Of ... | Option Exercise | M | 0.00 | 3,750 | 0 | 11,250 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Conway Charles | Chief Scientific Of ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Conway Charles | Chief Scientific Of ... | Option Exercise | A | 83.38 | 30,000 | 2,501,400 | 30,000 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Conway Charles | Chief Scientific Of ... | Payment of Exercise | F | 83.38 | 1,747 | 145,665 | 10,012 | 11.8 K to 10 K (-14.86 %) |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Conway Charles | Chief Scientific Of ... | Buy | M | 0.00 | 3,750 | 0 | 11,759 | 8 K to 11.8 K (+46.82 %) |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Option Exercise | M | 0.00 | 12,500 | 0 | 37,500 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Option Exercise | A | 83.38 | 100,000 | 8,338,000 | 100,000 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Payment of Exercise | F | 83.38 | 5,802 | 483,771 | 19,409 | 25.2 K to 19.4 K (-23.01 %) |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Buy | M | 0.00 | 12,500 | 0 | 25,211 | 12.7 K to 25.2 K (+98.34 %) |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Option Exercise | M | 0.00 | 1,250 | 0 | 3,750 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Option Exercise | A | 83.38 | 10,000 | 833,800 | 10,000 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Payment of Exercise | F | 83.38 | 492 | 41,023 | 2,659 | 3.2 K to 2.7 K (-15.61 %) |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Buy | M | 0.00 | 1,250 | 0 | 3,151 | 1.9 K to 3.2 K (+65.75 %) |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Option Exercise | M | 0.00 | 5,000 | 0 | 15,000 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Option Exercise | A | 83.38 | 40,000 | 3,335,200 | 40,000 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Payment of Exercise | F | 83.38 | 2,124 | 177,099 | 7,127 | 9.3 K to 7.1 K (-22.96 %) |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Buy | M | 0.00 | 5,000 | 0 | 9,251 | 4.3 K to 9.3 K (+117.62 %) |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Option Exercise | M | 0.00 | 1,250 | 0 | 3,750 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Option Exercise | M | 0.00 | 3,750 | 0 | 11,250 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Option Exercise | A | 83.38 | 30,000 | 2,501,400 | 30,000 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Buy | M | 0.00 | 1,250 | 0 | 2,187 | 937 to 2.2 K (+133.40 %) |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Payment of Exercise | F | 83.38 | 1,747 | 145,665 | 5,691 | 7.4 K to 5.7 K (-23.49 %) |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Buy | M | 0.00 | 3,750 | 0 | 7,438 | 3.7 K to 7.4 K (+101.68 %) |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | SVP, Clinical Opera ... | Option Exercise | M | 0.00 | 3,750 | 0 | 11,250 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | SVP, Clinical Opera ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | SVP, Clinical Opera ... | Option Exercise | A | 83.38 | 30,000 | 2,501,400 | 30,000 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | SVP, Clinical Opera ... | Payment of Exercise | F | 83.38 | 1,747 | 145,665 | 7,691 | 9.4 K to 7.7 K (-18.51 %) |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | SVP, Clinical Opera ... | Buy | M | 0.00 | 3,750 | 0 | 9,438 | 5.7 K to 9.4 K (+65.93 %) |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,750 | 0 | 11,250 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Option Exercise | A | 83.38 | 30,000 | 2,501,400 | 30,000 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Payment of Exercise | F | 83.38 | 1,747 | 145,665 | 9,211 | 11 K to 9.2 K (-15.94 %) |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Buy | M | 0.00 | 3,750 | 0 | 10,958 | 7.2 K to 11 K (+52.03 %) |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Conway Charles | Chief Scientific Of ... | Option Exercise | M | 0.00 | 3,750 | 0 | 11,250 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Conway Charles | Chief Scientific Of ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Conway Charles | Chief Scientific Of ... | Option Exercise | A | 83.38 | 30,000 | 2,501,400 | 30,000 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Conway Charles | Chief Scientific Of ... | Payment of Exercise | F | 83.38 | 1,747 | 145,665 | 10,012 | 11.8 K to 10 K (-14.86 %) |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Conway Charles | Chief Scientific Of ... | Buy | M | 0.00 | 3,750 | 0 | 11,759 | 8 K to 11.8 K (+46.82 %) |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Option Exercise | M | 0.00 | 12,500 | 0 | 37,500 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Option Exercise | A | 83.38 | 100,000 | 8,338,000 | 100,000 | |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Payment of Exercise | F | 83.38 | 5,802 | 483,771 | 19,409 | 25.2 K to 19.4 K (-23.01 %) |
Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Buy | M | 0.00 | 12,500 | 0 | 25,211 | 12.7 K to 25.2 K (+98.34 %) |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Option Exercise | M | 0.00 | 1,250 | 0 | 2,500 | |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Payment of Exercise | F | 90.14 | 480 | 43,267 | 1,540 | 2 K to 1.5 K (-23.76 %) |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Buy | M | 0.00 | 1,250 | 0 | 2,020 | 770 to 2 K (+162.34 %) |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Option Exercise | M | 0.00 | 1,250 | 0 | 2,500 | |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Option Exercise | M | 0.00 | 3,375 | 0 | 6,750 | |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Payment of Exercise | F | 90.14 | 480 | 43,267 | 1,540 | 2 K to 1.5 K (-23.76 %) |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Payment of Exercise | F | 90.14 | 1,531 | 138,004 | 3,688 | 5.2 K to 3.7 K (-29.34 %) |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Buy | M | 0.00 | 1,250 | 0 | 2,020 | 770 to 2 K (+162.34 %) |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Buy | M | 0.00 | 3,375 | 0 | 5,219 | 1.8 K to 5.2 K (+183.03 %) |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Option Exercise | M | 0.00 | 3,375 | 0 | 6,750 | |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Option Exercise | M | 0.00 | 3,000 | 0 | 6,000 | |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Payment of Exercise | F | 90.14 | 1,531 | 138,004 | 3,688 | 5.2 K to 3.7 K (-29.34 %) |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Payment of Exercise | F | 90.14 | 1,245 | 112,224 | 3,510 | 4.8 K to 3.5 K (-26.18 %) |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Buy | M | 0.00 | 3,375 | 0 | 5,219 | 1.8 K to 5.2 K (+183.03 %) |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Buy | M | 0.00 | 3,000 | 0 | 4,755 | 1.8 K to 4.8 K (+170.94 %) |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Option Exercise | M | 0.00 | 3,000 | 0 | 6,000 | |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | SVP, Clinical Opera ... | Option Exercise | M | 0.00 | 3,750 | 0 | 7,500 | |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Payment of Exercise | F | 90.14 | 1,245 | 112,224 | 3,510 | 4.8 K to 3.5 K (-26.18 %) |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | SVP, Clinical Opera ... | Payment of Exercise | F | 90.14 | 1,701 | 153,328 | 5,688 | 7.4 K to 5.7 K (-23.02 %) |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Buy | M | 0.00 | 3,000 | 0 | 4,755 | 1.8 K to 4.8 K (+170.94 %) |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | SVP, Clinical Opera ... | Buy | M | 0.00 | 3,750 | 0 | 7,389 | 3.6 K to 7.4 K (+103.05 %) |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | SVP, Clinical Opera ... | Option Exercise | M | 0.00 | 3,750 | 0 | 7,500 | |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,700 | 0 | 7,400 | |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | SVP, Clinical Opera ... | Payment of Exercise | F | 90.14 | 1,701 | 153,328 | 5,688 | 7.4 K to 5.7 K (-23.02 %) |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Payment of Exercise | F | 90.14 | 1,678 | 151,255 | 6,544 | 8.2 K to 6.5 K (-20.41 %) |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | SVP, Clinical Opera ... | Buy | M | 0.00 | 3,750 | 0 | 7,389 | 3.6 K to 7.4 K (+103.05 %) |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Buy | M | 0.00 | 3,700 | 0 | 8,222 | 4.5 K to 8.2 K (+81.82 %) |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,700 | 0 | 7,400 | |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Option Exercise | M | 0.00 | 10,950 | 0 | 21,900 | |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Payment of Exercise | F | 90.14 | 1,678 | 151,255 | 6,544 | 8.2 K to 6.5 K (-20.41 %) |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Payment of Exercise | F | 90.14 | 4,965 | 447,545 | 11,970 | 16.9 K to 12 K (-29.32 %) |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Buy | M | 0.00 | 3,700 | 0 | 8,222 | 4.5 K to 8.2 K (+81.82 %) |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Buy | M | 0.00 | 10,950 | 0 | 16,935 | 6 K to 16.9 K (+182.96 %) |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Option Exercise | M | 0.00 | 10,950 | 0 | 21,900 | |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Conway Charles | Chief Scientific Of ... | Option Exercise | M | 0.00 | 3,000 | 0 | 6,000 | |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Payment of Exercise | F | 90.14 | 4,965 | 447,545 | 11,970 | 16.9 K to 12 K (-29.32 %) |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Conway Charles | Chief Scientific Of ... | Payment of Exercise | F | 90.14 | 1,361 | 122,681 | 7,278 | 8.6 K to 7.3 K (-15.75 %) |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Buy | M | 0.00 | 10,950 | 0 | 16,935 | 6 K to 16.9 K (+182.96 %) |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Conway Charles | Chief Scientific Of ... | Buy | M | 0.00 | 3,000 | 0 | 8,639 | 5.6 K to 8.6 K (+53.20 %) |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Conway Charles | Chief Scientific Of ... | Option Exercise | M | 0.00 | 3,000 | 0 | 6,000 | |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Conway Charles | Chief Scientific Of ... | Payment of Exercise | F | 90.14 | 1,361 | 122,681 | 7,278 | 8.6 K to 7.3 K (-15.75 %) |
Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Conway Charles | Chief Scientific Of ... | Buy | M | 0.00 | 3,000 | 0 | 8,639 | 5.6 K to 8.6 K (+53.20 %) |
Nov 23 2020 | BHVN | Biohaven Pharmaceu ... | CHILDS JOHN W | Buy | P | 89.55 | 5,000 | 447,737 | 2,516,938 | 2.5 M to 2.5 M (+0.20 %) | |
Nov 23 2020 | BHVN | Biohaven Pharmaceu ... | CHILDS JOHN W | Buy | P | 89.55 | 5,000 | 447,737 | 2,516,938 | 2.5 M to 2.5 M (+0.20 %) | |
Nov 04 2020 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Option Exercise | M | 50.72 | 30,000 | 1,521,600 | 50,000 | |
Nov 04 2020 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Sell | S | 77.70 | 1,300 | 101,005 | 1,755 | 3.1 K to 1.8 K (-42.55 %) |
Nov 04 2020 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Sell | S | 77.01 | 4,010 | 308,799 | 3,055 | 7.1 K to 3.1 K (-56.76 %) |
Nov 04 2020 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Sell | S | 76.02 | 24,690 | 1,876,872 | 7,065 | 31.8 K to 7.1 K (-77.75 %) |
Nov 04 2020 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Buy | M | 50.72 | 30,000 | 1,521,600 | 31,755 | 1.8 K to 31.8 K (+1,709.40 %) |
Oct 23 2020 | BHVN | Biohaven Pharmaceu ... | Bailey Gregory | Sell | S | 79.94 | 212 | 16,948 | 2,545,658 | 2.5 M to 2.5 M (-0.01 %) | |
Oct 23 2020 | BHVN | Biohaven Pharmaceu ... | Bailey Gregory | Sell | S | 78.89 | 10,191 | 803,918 | 2,545,870 | 2.6 M to 2.5 M (-0.40 %) | |
Oct 23 2020 | BHVN | Biohaven Pharmaceu ... | Bailey Gregory | Sell | S | 79.88 | 3,100 | 247,632 | 2,556,061 | 2.6 M to 2.6 M (-0.12 %) | |
Oct 23 2020 | BHVN | Biohaven Pharmaceu ... | Bailey Gregory | Sell | S | 79.94 | 212 | 16,948 | 2,545,658 | 2.5 M to 2.5 M (-0.01 %) | |
Oct 23 2020 | BHVN | Biohaven Pharmaceu ... | Bailey Gregory | Sell | S | 79.41 | 21,466 | 1,704,720 | 2,559,161 | 2.6 M to 2.6 M (-0.83 %) | |
Oct 23 2020 | BHVN | Biohaven Pharmaceu ... | Bailey Gregory | Sell | S | 78.89 | 10,191 | 803,918 | 2,545,870 | 2.6 M to 2.5 M (-0.40 %) | |
Oct 23 2020 | BHVN | Biohaven Pharmaceu ... | Bailey Gregory | Sell | S | 79.88 | 3,100 | 247,632 | 2,556,061 | 2.6 M to 2.6 M (-0.12 %) | |
Oct 23 2020 | BHVN | Biohaven Pharmaceu ... | Bailey Gregory | Sell | S | 79.41 | 21,466 | 1,704,720 | 2,559,161 | 2.6 M to 2.6 M (-0.83 %) | |
Oct 21 2020 | BHVN | Biohaven Pharmaceu ... | Bailey Gregory | Sell | S | 78.98 | 4,554 | 359,655 | 2,580,627 | 2.6 M to 2.6 M (-0.18 %) | |
Oct 21 2020 | BHVN | Biohaven Pharmaceu ... | Bailey Gregory | Sell | S | 78.98 | 4,554 | 359,655 | 2,580,627 | 2.6 M to 2.6 M (-0.18 %) | |
Oct 21 2020 | BHVN | Biohaven Pharmaceu ... | Bailey Gregory | Sell | S | 78.88 | 3,748 | 295,638 | 2,585,181 | 2.6 M to 2.6 M (-0.14 %) | |
Oct 21 2020 | BHVN | Biohaven Pharmaceu ... | Bailey Gregory | Sell | S | 78.88 | 3,748 | 295,638 | 2,585,181 | 2.6 M to 2.6 M (-0.14 %) | |
Oct 14 2020 | BHVN | Biohaven Pharmaceu ... | Bailey Gregory | Sell | S | 78.87 | 6,729 | 530,740 | 2,588,929 | 2.6 M to 2.6 M (-0.26 %) | |
Oct 14 2020 | BHVN | Biohaven Pharmaceu ... | Bailey Gregory | Sell | S | 78.87 | 6,729 | 530,740 | 2,588,929 | 2.6 M to 2.6 M (-0.26 %) | |
Sep 22 2020 | BHVN | Biohaven Pharmaceu ... | CHILDS JOHN W | Buy | P | 59.25 | 3,322 | 196,829 | 2,511,938 | 2.5 M to 2.5 M (+0.13 %) | |
Sep 22 2020 | BHVN | Biohaven Pharmaceu ... | CHILDS JOHN W | Buy | P | 59.25 | 3,322 | 196,829 | 2,511,938 | 2.5 M to 2.5 M (+0.13 %) | |
Sep 14 2020 | BHVN | Biohaven Pharmaceu ... | CHILDS JOHN W | Buy | P | 59.00 | 6,678 | 393,984 | 2,508,616 | 2.5 M to 2.5 M (+0.27 %) |